IMS MAXIMS Releases Improved Version of Open Source EPR

IMS MAXIMSThis week sees the release of the latest version of the IMS MAXIMS open source electronic patient record (EPR), openMAXIMS, which includes all of the enhancements made for Taunton and Somerset NHS Foundation Trust. Taunton was the first trust to go live with the software and has been working closely with IMS MAXIMS on the new functionality.

The upgraded code is now available on the open source website (GitHub), with many new features, including clinical triage of referrals to direct patients to the appropriate service and care according to clinical priority, and pre-operative assessment for theatres, ensuring patients are fit and suitable for surgery.

The IMS MAXIMS open source EPR was first made available to the NHS in June 2014 and is available for anyone world-wide to download and use for free. The ambition being to offer more flexibility and choice to trusts and increase the number of users that could help develop the code, for the benefit of the wider NHS and elsewhere. Eighteen months on, there is 50% more source code offering users more functionality than ever before.

Paul Cooper, research director at IMS MAXIMS said: "The open source approach is really maturing in the NHS, as trusts look to achieve value for money when procuring EPRs. This release demonstrates our commitment to the ongoing development of the solution. NHS trusts looking to adopt openMAXIMS will benefit greatly from the developments made for Taunton, whose clinicians were involved throughout the design of the system, ensuring it suited the trust’s clinical needs and processes across A&E, theatres, outpatients and the hospital’s 30 wards."

IMS MAXIMS has also contracted with Ramsay Health Care, Wye Valley NHS Trust and Blackpool Teaching Hospitals NHS Foundation Trust, to help deploy and maintain openMAXIMS. Further updates of the code are in the pipeline as major milestones are reached across customer deployments.

Cooper continued: "We have not only added new features to this release but have made numerous enhancements throughout the entire code base. We are continuing to develop the software to meet the additional requirements of phase two at Taunton, Ramsay and Wye Valley, all of which will be going live in 2016."

Dr Chris Swinburn, clinical lead for the project at Taunton, said last September that the trust had: "developed a robust EPR system that can be replicated in other hospitals. This can deliver wide reaching benefits across the NHS."

To download the openMAXIMS code visit the GitHub website.

About IMS MAXIMS
IMS MAXIMS is a pioneering clinical technology specialist committed to improving the coordination of patient care in healthcare environments. Its expert team works in partnership with healthcare organisations to identify and deliver tailored, sustainable information sharing technology solutions, supporting the provision of safer and more efficient care for current and future generations.

The organisation’s 29-year history of collaborating with clinicians has resulted in the development of proven, flexible, user-friendly, safe and interoperable open source electronic patient record software.

With an ambition to meet today’s healthcare challenges, IMS MAXIMS makes its software freely available and offers flexible options to support healthcare providers with implementation and maintenance. Its open technology has increased collaboration in the development of the software, which has resulted in better clinical engagement and empowerment across hospital wards and departments.

Deployment times are fast, meaning clinicians and patients can benefit from efficiency and safety improvements quickly. It is used across 180 healthcare organisations and by 30,000 users each day, to provide clinically-led technology solutions for over 13 million patients.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

Bayer Grants4Apps® Dealmaker Berlin 2017

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts...